BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Novo Nordisk A/S 

Novo Allé

Bagsvaerd    2880  Denmark
Phone: 45-4444-8888 Fax: 45-4449-0555


SEARCH JOBS




Industry
Big Pharma


Collaborations

CelTor Biosystems, Inc.  Research collaboration

Aradigm Corporation  Commercial agreement to develop AERx technology for the delivery of insulin, insulin analogues and other glucose-lowering agents for diabetes management.

Incyte Corporation 

Maxygen, Inc. 

Intergen Company 





 Company News
European Medicines Agency Release: Novo Nordisk A/S (NVO)'s Saxenda Recommended For Approval In Weight Management In Adults 1/23/2015 9:22:26 AM
Novo Nordisk A/S (NVO) Plans to Use 500 Sales Reps to Promote New Obesity Drug 12/30/2014 6:28:57 AM
Novo Nordisk A/S (NVO) Already Seeking Successor for CEO That Will Most Likely Step Down in 2019 12/29/2014 6:16:30 AM
Novo Nordisk A/S (NVO) Receives FDA Approval For Saxenda® For The Treatment Of Obesity 12/24/2014 6:07:42 AM
SoCal's Xencor Snags $175 Million+ R&D Pact With Novo Nordisk A/S (NVO) 12/18/2014 6:13:06 AM
Novo Nordisk A/S (NVO) And Chip Ganassi Racing Teams Announce Multi-Year Sponsorship Agreement For Verizon Indycar Series 12/12/2014 8:08:36 AM
Novo Nordisk A/S (NVO) Release: Novoeight Phase 3 Data Show Reduction In Annualised Bleeding Rate Over Time In People With Haemophilia A 12/8/2014 7:45:24 AM
Novo Nordisk A/S (NVO) To Present Hemophilia Portfolio And Pipeline Data At 56th American Society of Hematology Meeting 12/1/2014 4:01:03 PM
Novo Nordisk A/S (NVO) Restructures Executive Board As Chief Of Staff Leaves 11/26/2014 6:27:04 AM
Amneal Pharmaceuticals Launches AG For Novo Nordisk A/S (NVO)’s Activella® 11/20/2014 11:13:28 AM
12345678910...